10th Annual Conference - Hellenic Cancer Federation (ELLOK)

10th Annual Conference

People at the Centre - Bridging Pathways of Care

2-4 February 2026

About the Conference

The Hellenic Cancer Federation - ELLOK is organising its 10th Annual Conference aligned with World Cancer Day (4th February). This conference serves as a key reference point for highlighting critical issues in health and cancer care.

At a time of international instability and increasing pressures on health systems, Greece has made significant progress in public health and in the care of oncology patients. However, ensuring the sustainability of the health system requires targeted structural reforms, improved access to modern therapies, investment in the healthcare workforce, and the adoption of artificial intelligence to create a more effective, equitable, and human-centred health system.

In this context, the 10th Annual Conference of the Hellenic Cancer Federation aims to highlight European and national challenges, propose realistic solutions, and strengthen meaningful dialogue among policymakers, the academic and scientific community, the health industry and patient representatives.

Key Thematic Areas

National Strategy and Health Policies

  • National Cancer Action Plan
  • Implementing the digital transformation of oncology care
  • Addressing inequalities and improving access to cancer care
  • Pharmaceutical policy as a driver of investment and growth in health
  • Health Value Assessment: Measuring Efficiency and Evaluating Health Technologies (HTA)

Public Health, Prevention, and Integrated Care

  • Mental Health as an Integral Part of Cancer Care
  • Intervening in Social Behaviors / Focusing on Tobacco Products and Obesity
  • The Role of Exercise and Nutrition in Cancer Management
  • Lung Cancer as a Major Public Health Issue
  • There Are Also the Rare Ones: What We Know About Brain Tumors

Clinical Practice, Research, and Innovation

  • Clinical Trials in a Changing International Environment
  • The Impact of Geopolitical Developments on Patient Access to Innovation
  • The Added Value of Biosimilars and Generics
  • Liquid Biopsy and Next-Generation Sequencing (NGS)
  • Comprehensive Cancer Centers (CCCs): The Challenge for Excellence in Cancer Care

Digital Health and Technology

  • National Strategy for Digital Transformation in Health
  • The Contribution of Artificial Intelligence to Improving Oncology Care
  • Digital Health Services (1566 – MyHealth)
  • Leveraging Digital Systems and Technologies for Patients and Caregivers
  • New EHDS Framework: Secure Exchange & Utilisation of Health Data

Featured Speakers

The conference brings together distinguished experts from healthcare policy, clinical practice, research, and patient advocacy.

GEORGIADIS ADONIS
Minister of Health
Government Representative
AGAPIDAKI EIRINI
Deputy Minister of Health
Government Representative
KAPETANAKIS GIORGOS
President of the Hellenic Cancer Federation
Conference Host
AAPRO MATTI
Professor, Cancer Centre Genolier, Switzerland
International Expert
KYRIAKIDES STELLA
Former European Commissioner for Health and Food Safety
EU Policy Expert
BREDA JOAO
Head, WHO Athens Quality of Care and Patient Safety Office
WHO Representative

And many more distinguished speakers from the fields of oncology, healthcare policy, research, and patient advocacy.

Aligned with World Cancer Day

The date of the Conference, as every year, is aligned with World Cancer Day (4th February). This synchronization emphasizes our commitment to global cancer awareness and the continuous effort to improve cancer care and patient support worldwide.

The conference aims to bridge pathways of care, placing people at the center of all discussions and initiatives. By fostering collaboration between policymakers, healthcare professionals, researchers, and patient advocates, we work towards a more effective, equitable, and human-centred health system for all.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959